No photo of Michael W Fried
Contact Expert

View Scopus Profile

Michael W Fried

    • 20265 Citations
    • 59 h-Index
    1989 …2020
    If you made any changes in Pure these will be visible here soon.

    Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

    • 12 Similar Profiles
    Chronic Hepatitis C Medicine & Life Sciences
    Ribavirin Medicine & Life Sciences
    Hepacivirus Medicine & Life Sciences
    Hepatitis C Medicine & Life Sciences
    Therapeutics Medicine & Life Sciences
    Genotype Medicine & Life Sciences
    Interferons Medicine & Life Sciences
    Virus Diseases Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 1999 2020

    The Patient-Reported Outcomes Project of HCV-TARGET (PROP up TARGET)

    Stewart, P. W., Golin, C. E., Fried, M. W., Evon, D. M. & Reeve, B.

    Patient-Centered Outcomes Research Institute (PCORI)

    8/1/15 → 10/31/18

    Project: Research project

    Hepatitis C
    Therapeutics
    Health Expenditures
    Patient Reported Outcome Measures
    Patient Outcome Assessment

    Hepatitis B Research Network

    Fried, M. W., Evon, D. M., Darling, J. M. & McGivern, D.

    NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD)

    9/30/08 → 5/31/20

    Project: Research project

    Hepatitis B
    Research
    Guidelines
    Therapeutics
    Chronic Hepatitis B

    MK5172-065 - A Phase III Double Blind Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic HCV GT1, GT4 and GT6 Infection with Inherited Blood Disorders with and without HIV Co-Infection

    Fried, M. W.

    Industry Sponsor

    12/10/14 → 12/9/17

    Project: Research project

    Impact of antiretroviral therapy on liver fibrosis in Zambian HIV/HBV patients

    Fried, M. W.

    NIH Fogarty International Center for Advanced Study in the Health Sciences

    9/1/14 → 8/31/15

    Project: Research project

    Hepatitis B virus
    Liver Cirrhosis
    HIV
    Mentors
    Africa South of the Sahara

    A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B Cirrhosis

    Fried, M. W.

    Industry Sponsor

    8/27/14 → 8/26/17

    Project: Research project

    Research Output 1989 2018

    Parsing the guidelines on guidelines: Balancing sensibility and conflict of interest

    Zucker, S. D. & Fried, M. W., Sep 1 2018, In : Hepatology. 68, 3, p. 798-800 3 p.

    Research output: Contribution to journal › Editorial

    Conflict of Interest
    Guidelines
    2 Citations

    Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

    Evon, D. M., Amador, J., Stewart, P., Reeve, B. B., Lok, A. S., Sterling, R. K., Di Bisceglie, A. M., Reau, N., Serper, M., Sarkar, S., Lim, J. K., Golin, C. E. & Fried, M. W., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 7, p. 1001-1011 11 p.

    Research output: Contribution to journal › Article

    Chronic Hepatitis C
    Psychometrics
    Information Systems
    Antiviral Agents
    Hepacivirus
    1 Citations

    Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis

    HCV-TARGET Study Group, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

    Research output: Contribution to journal › Article

    Ribavirin
    Virus Diseases
    Hepacivirus
    Fibrosis
    Genotype

    The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial

    Proeschold-Bell, R. J., Evon, D. M., Makarushka, C., Wong, J. B., Datta, S. K., Yao, J., Patkar, A. A., Mannelli, P., Hodge, T., Naggie, S., Wilder, J. M., Fried, M. W., Niedzwiecki, D. & Muir, A. J., Sep 1 2018, In : Contemporary Clinical Trials. 72, p. 73-85 13 p.

    Research output: Contribution to journal › Article

    Hepatitis C
    Randomized Controlled Trials
    Alcohols
    Hepacivirus
    Therapeutics

    Controversies in hepatitis C therapy: Reactivation of hepatitis B virus

    Lieber, S. R. & Fried, M. W., Oct 1 2017, In : Clinical Liver Disease. 10, 4, p. 87-92 6 p.

    Research output: Contribution to journal › Review article

    Hepatitis C
    Hepatitis B virus
    Therapeutics